Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China flag China · Delayed Price · Currency is CNY
18.50
-0.56 (-2.94%)
At close: Jun 11, 2026

SHE:301263 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Cash & Equivalents
426.53579.72541.96455.64806.79137.63
Trading Asset Securities
150.0340.2122.1251.8240.65-
Cash & Short-Term Investments
576.56619.93664.06707.451,047137.63
Cash Growth
-10.97%-6.65%-6.13%-32.46%661.05%47.19%
Accounts Receivable
453.97364.56337.06353.04378.49315.95
Other Receivables
7.078.622.924.094.11.91
Receivables
461.04373.17339.98357.14382.59317.86
Inventory
103.3298.81105.0786.5580.5276.57
Other Current Assets
38.1640.6333.0836.1622.5311.01
Total Current Assets
1,1791,1331,1421,1871,533543.07
Property, Plant & Equipment
494.51500.76521.27483.74314.54260.24
Long-Term Investments
32.4532.4532.4532.4532.45-
Goodwill
216.66216.66216.66200.6427.3327.33
Other Intangible Assets
188.3189.51159.25158.1966.0144.46
Long-Term Deferred Tax Assets
97.6593.7857.0932.6434.1929.31
Long-Term Deferred Charges
245.78243.56174.87119.9826.2526.5
Other Long-Term Assets
11.7587.2814.185.7410.62
Total Assets
2,4662,4172,3112,2292,040941.52
Accounts Payable
171.35172.51168.37121.1956.5946.92
Accrued Expenses
9.8618.7519.5318.727.6419.68
Short-Term Debt
256.54249.91132.1453.8420.02107.57
Current Portion of Long-Term Debt
30.2128.7924.0912.08--
Current Portion of Leases
-1.421.581.231.170.96
Current Income Taxes Payable
23.089.3221.7837.0241.5416.55
Current Unearned Revenue
12.0412.953.214.195.189.04
Other Current Liabilities
30.937.774.264.894.173.76
Total Current Liabilities
534.01501.41374.95253.13156.33204.48
Long-Term Debt
69.6378.7984108--
Long-Term Leases
3.012.680.851.121.960.37
Long-Term Unearned Revenue
12.4713.0815.6516.1919.6619.08
Long-Term Deferred Tax Liabilities
18.1418.7519.2121.287.687.79
Other Long-Term Liabilities
62.4661.36----
Total Liabilities
699.72676.07494.67399.72185.63231.71
Common Stock
425.5425.5425.5425.5236.39177.29
Additional Paid-In Capital
853.99857.24896.7900.771,109116.16
Retained Earnings
456.59428.01484.08502.91508.18416.3
Treasury Stock
-39-39-39-39--
Comprehensive Income & Other
-0.24-0.5-0.22-0.190.410.21
Total Common Equity
1,6971,6711,7671,7901,854709.96
Minority Interest
69.6469.9549.3339.41-0.16-0.15
Shareholders' Equity
1,7661,7411,8161,8291,854709.81
Total Liabilities & Equity
2,4662,4172,3112,2292,040941.52
Total Debt
359.39361.59242.65176.2723.16108.9
Net Cash (Debt)
217.17258.34421.41531.181,02428.73
Net Cash Growth
-33.41%-38.70%-20.67%-48.14%3465.41%-
Net Cash Per Share
0.450.530.841.052.150.08
Filing Date Shares Outstanding
508.21508.21508.21508.21510.6510.6
Total Common Shares Outstanding
508.21508.21508.21508.21510.6382.94
Working Capital
645.07631.14767.24934.161,377338.59
Book Value Per Share
3.343.293.483.523.631.85
Tangible Book Value
1,2921,2651,3911,4311,761638.18
Tangible Book Value Per Share
2.542.492.742.823.451.67
Buildings
-441.97448.01208.1205.74207.64
Machinery
-299.02284.45203.9187.35171.81
Construction In Progress
-17.372.44247.0266.372.01